BridgeMD
New treatment option for Cardiac Amyloidosis
Official title PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
ClinicalTrials.gov ID: NCT05098665
What this study is testing
What is Telemonitoring service?
Telemonitoring service is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for cardiac amyloidosis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Cardiac amyloidosis is a condition where the heart muscle, amongst other tissues, is infiltrated by the abnormal build-up of proteins called amyloid. This stiffens and thickens the heart muscle over time which makes it less efficient and puts further stress and strain on the other chambers of the heart, leading to heart failure.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged ≥18 at the date of signing informed consent which is defined as the beginning of the Screening Period.
- An established diagnosis of ATTR cardiomyopathy as defined by protocol.
- Ability to provide written, personally signed and dated informed consent to participate in the study, in accordance with the ICH Good Clinical...
- An understanding, ability, and willingness to fully comply with study procedures and restrictions.
- Currently a patient at a study site (NAC).
You likely can't join if
- An inability to have or use BodyTrace device scales at usual residence (for example no mobile network cellular signal)
- On dialysis or end-stage renal failure (eGFR \<25mL/min)
- Serum albumin \<20g/dL or other non-hypervolaemia cause of tissue oedema (e.g. protein-losing enteropathy, nephrotic syndrome)
- Use of greater than 2 oral diuretics (e.g. on maximum oral diuretic therapy)
The study team makes the final eligibility decision.
Where it's taking place
- London, London, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.